 SINGAPORE, Nov. 19, 2020 GLOBE NEWSWIRE -- ASLAN Pharmaceuticals Nasdaq:ASLN, a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, Chief Executive Officer of the company, will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held from 30 November to 3 December 2020. 